I spoke to my Gastro regarding the Anemia factor with Victrelis. He said it was no big deal and readily controlled with Procrit. He's had a lot of success with Procrit and his patients. I've been fortunate to not have the Anemia problem through four tries, but if we face that problem, then Procrit.
The rash on the other hand is not easily controlled and in his opinion is a big factor with Incevik. How your insurance company deals with switching PI's is another consideration. Will they allow you to switch if you get the rash with Incevik? that's an important question. At any rate, whatever you choose, good luck in clearing...
Magnum
Hi. Hope you get what you want. I wanted BOC, but at first my GI said no because of my anemia. I was NOT looking forward to any more itch or rash than I've had with SOC. Then he changed his mind and said I would go on Procrit quickly. Of corse BCBS denied it but once the anemia kicks in, I should be OK.
I will do whatever I have to. There's no dropout from this girl.
hi magnum,
spoke with a hepatologist this week, who was an investigator in the incevik trials but not victrellis. the doc said they will be using both PIs in their clinic. their first patient they are treating after approval is receiving victrelis.
eric
It will be at least 6 weeks before I tx and I am planning to request Victrelis instead of Incevik because of the severe skin rash probability. I already have sensitive skin problems and I can't imagine what Incevik would do... I hope my insurance plan won't try to insist on which drug to approve.
My doctor, who I am trying to work all this out with, also suggest not adding the 3rd drug and staying with SOC because of the horrendous rash. She stated 58% drop out rate because of it. She wants to do the lead in then add the Teaprevir if needed. I decided to go with that decision. My gene is CC, genotype 1a, HIGH VL, female, small.
I can only relay my Gastro's take on Victrelis after studies he's seen. The other reason he wants me on it is the absence (hopefully) of the horrendous rash, in which studies he’s seen showed that 30% have dropped out of therapy because of rash intolerance and suffering beyond reason. To him, that’s too high of a rate of drop-outs. You're right to run this by your Hepatologist, as my doctor has yet to catch up on the final studies of Telaprevir. Best of luck to you...
Mag
Very interesting, indeed.
First, I wonder where this information is coming from that with the Incevik(Telaprevir) the virus comes back after the intial drop. Any ideas? Seen that in any studies? The only reason I can think of for denying Vitrelis and approving the Incevik is that the SVR rates are slightly higher.
I am going to see if I can get any kind of info from my insurance company before I go to see the heppo next Friday.
What additional info do they want from you?
frijole
If denied why not apply for Mercks Patient Assistance Program???
Good luck guy,
cando
Hi, Magnum. I got a lot of pleasure from reading your post, since the only thing I hate as much as pharmaceutical companies and the AMA is insurance companies. Maybe it's time for a class-action lawsuit (like170 million HCV infectees in the class!), to force the insurance companies to sell their skyscrapers and give triple therapy to us all?
Mike
i have had battles with insurance that make my blood boil. i sure wish u success this time.
best to u! babs